WebMar 6, 2024 · CTI develops novel therapies for patients with rare blood-related cancers by uncovering the underlying scientific drivers of their disease. Learn More Approved in the U.S. for adults with myelofibrosis … WebKey People CTI BioPharma Corp. Board of Directors Name/Title Current Board Membership expand All Executives Adam R. Craig President, CEO, Chief Medical Officer & Director David H. Kirske...
Did you know?
WebMay 13, 2024 · CTI BioPharma and biotech stocks across the board have been having a hard time getting investors' attention recently. As a result, it looks like a bargain right now. Even after Friday's big... WebSep 27, 2005 · Cell Therapeutics, Inc. (CTIC) Message Board - Company Name: Cell Therapeutics, Inc., Stock Symbol: CTIC, Industry: Medical - Drugs - Total Posts: 7223 - Last Post: 03/10/2024 10:06:03 AM - company/specific stock board ... CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 04/10/2024 …
WebMr. Metzger joined CTI BioPharma’s Board in January 2024. Mr. Metzger is currently president and chief operating officer of Syndax Pharmaceuticals, Inc., a publicly traded immuno-oncology biopharmaceutical company. Mr. WebMar 21, 2024 · The equity awards were approved on March 20, 2024, in accordance with Nasdaq Listing Rule 5635 (c) (4). The employees received options to purchase an aggregate of 124,000 shares of CTI BioPharma ...
WebOct 3, 2016 · SEATTLE, Oct. 3, 2016 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA:CTIC) today announced that James A. Bianco, M.D, CTI BioPharma's President and Chief Executive Officer, has retired from the Company effective on October 2 nd.At the request of the Board of Directors, Richard Love, a director of CTI … WebApr 11, 2024 · SEATTLE, April 10, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and …
WebJan 13, 2016 · SEATTLE, Jan. 13, 2016 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that Matthew Perry, President of BVF Partners L.P. (BVF Partners) and CTI...
WebApr 10, 2024 · The equity awards were approved on April 10, 2024, in accordance with Nasdaq Listing Rule 5635 (c) (4). The employees received options to purchase an … in accounting assets representWebApr 10, 2024 · SEATTLE, April 10, 2024 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ:CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for ... inat box windows indirWebAug 24, 2024 · CTI BioPharma Corp. Aug 24, 2024, 07:00 ET. SEATTLE, Aug. 24, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced the … inat boxcWeb1 day ago · CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of … inat box v12 apk indirWebSEATTLE , Jan. 24, 2024 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted an equity award to a new employee as an equity inducement award outside of the Company's Amended and Restated Jan 05, 2024 in accounting best practicesWebMar 21, 2024 · The equity awards were approved on March 20, 2024, in accordance with Nasdaq Listing Rule 5635 (c) (4). The employees received options to purchase an … in accounting a debit is increase or decreaseWebCTI BioPharma is a Seattle based biopharmaceutical company focused on the development and commercialization of novel therapies that address unique unmet medical needs for patients suffering from blood-related … inat box windows 11